Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Carcinoma, Bronchogenic 1

Interventions

Carboplatin 5 Pemetrexed 4 pembrolizumab 3 Paclitaxel 2 Gemcitabine 2 Cisplatin 2 pralsetinib 1 camrelizumab 1 Vinorelbine 1 TNFSF10 protein, human 1 Nivolumab 1 Mediastinoscopy 1 Magnetic Resonance Spectroscopy 1 Injections 1 Docetaxel 1 Bronchoscopy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Bronchogenic × Mediastinoscopy × Clear all

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡